Mechanisms of Cellular Activation in the Antiphospholipid Syndrome

Seminars in Thrombosis and Hemostasis

Volumn 44, Issue 5, 2018, Pages 483-492

  Müller Calleja, Nadine ^a   Lackner, Karl J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

annexins; antiphospholipid antibodies; low density lipoprotein receptor related protein 8; NADPH oxidase; signal transduction; toll like receptors

Indexed keywords

APOLIPOPROTEIN E RECEPTOR 2; COMPLEMENT; LIPOCORTIN 2; LIPOCORTIN 5; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 8; MAMMALIAN TARGET OF RAPAMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ENDOSOME; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; IMMUNOLOGY;

ANTIPHOSPHOLIPID SYNDROME; HUMANS; SIGNAL TRANSDUCTION;

EID: 85011816623     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1597290     Document Type: Article

References (100)

1. Branch D. W. Dudley D. J. Mitchell M. D., et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol: 1990; 163 (1, Pt 1): 210 216
2. Blank M. Cohen J. Toder V. Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A: 1991; 88 08 3069 3073
3. Pierangeli S. S. Barker J. H. Stikovac D., et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost: 1994; 71 05 670 674
4. Poulton K. Rahman A. Giles I. Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. Semin Arthritis Rheum: 2012; 41 05 720 736
5. 2 -Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood: 2011; 117 12 3453 3459
6. Pericleous C. Ruiz-Limón P. Romay-Penabad Z., et al. Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis. Rheumatology (Oxford): 2015; 54 04 722 727
7. Branch D. W. Rodgers G. M. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol: 1993; 168 (1, Pt 1): 206 210
8. Kornberg A. Blank M. Kaufman S. Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol: 1994; 153 03 1328 1332
9. Reverter J. C. Tàssies D. Font J., et al. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum: 1998; 41 08 1420 1427
10. Xie H. Sheng L. Zhou H. Yan J. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Br J Haematol: 2014; 164 02 165 176
11. Zhang J. McCrae K. R. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood: 2005; 105 05 1964 1969
12. Clemens N. Frauenknecht K. Katzav A. Sommer C. von Landenberg P. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes. Ann N Y Acad Sci: 2009; 1173 805 813
13. Prinz N. Clemens N. Canisius A. Lackner K. J. Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Lessons from the antiphospholipid syndrome. Thromb Haemost: 2013; 109 03 525 531
14. Mulla M. J. Brosens J. J. Chamley L. W., et al. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol: 2009; 62 02 96 111
15. Pierangeli S. S. Vega-Ostertag M. Harris E. N. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res: 2004; 114 05/06 467 476
16. Katzav A. Menachem A. Maggio N. Pollak L. Pick C. G. Chapman J. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. J Autoimmun: 2014; 55 86 93
17. Gladigau G. Haselmayer P. Scharrer I., et al. A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PLoS One: 2012; 7 07 e42176
18. Sun K. H. Liu W. T. Tsai C. Y. Liao T. S. Lin W. M. Yu C. L. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis: 1992; 51 06 707 712
19. Prinz N. Clemens N. Strand D., et al. Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. Blood: 2011; 118 08 2322 2332
20. Pierangeli S. S. Liu S. W. Anderson G. Barker J. H. Harris E. N. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation: 1996; 94 07 1746 1751
21. Gerke V. Moss S. E. Annexins: from structure to function. Physiol Rev: 2002; 82 02 331 371
22. He K. L. Deora A. B. Xiong H., et al. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem: 2008; 283 28 19192 19200
23. Hou Y. Yang L. Mou M., et al. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Invest: 2008; 26 08 809 815
24. Babiychuk E. B. Draeger A. Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains. J Cell Biol: 2000; 150 05 1113 1124
25. Oliferenko S. Paiha K. Harder T., et al. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol: 1999; 146 04 843 854
26. Bharadwaj A. Bydoun M. Holloway R. Waisman D. Annexin A2 heterotetramer: structure and function. Int J Mol Sci: 2013; 14 03 6259 6305
27. Ma K. Simantov R. Zhang J. C. Silverstein R. Hajjar K. A. McCrae K. R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem: 2000; 275 20 15541 15548
28. Zhou H. Ling S. Yu Y. Wang T. Hu H. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. Cell Res: 2007; 17 08 737 739
29. Romay-Penabad Z. Montiel-Manzano M. G. Shilagard T., et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood: 2009; 114 14 3074 3083
30. Bellagamba C. Hubaishy I. Bjorge J. D. Fitzpatrick S. L. Fujita D. J. Waisman D. M. Tyrosine phosphorylation of annexin II tetramer is stimulated by membrane binding. J Biol Chem: 1997; 272 06 3195 3199
31. Urbanus R. T. Derksen R. H. de Groot P. G. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev: 2008; 22 02 93 105
32. Cockrell E. Espinola R. G. McCrae K. R. Annexin A2: biology and relevance to the antiphospholipid syndrome. Lupus: 2008; 17 10 943 951
33. Allen K. L. Fonseca F. V. Betapudi V. Willard B. Zhang J. McCrae K. R. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood: 2012; 119 03 884 893
34. Chaturvedi S. Alluri R. McCrae K. R. Extracellular vesicles in the antiphospholipid syndrome. Semin Thromb Hemost: 2018; 44 05 493 504
35. Funakoshi T. Heimark R. L. Hendrickson L. E. McMullen B. A. Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry: 1987; 26 17 5572 5578
36. Tait J. F. Sakata M. McMullen B. A., et al. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. Biochemistry: 1988; 27 17 6268 6276
37. Mosser G. Ravanat C. Freyssinet J. M. Brisson A. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol: 1991; 217 02 241 245
38. Voges D. Berendes R. Burger A. Demange P. Baumeister W. Huber R. Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study. J Mol Biol: 1994; 238 02 199 213
39. Reviakine I. Bergsma-Schutter W. Brisson A. Growth of protein 2-D crystals on supported planar lipid bilayers imaged in situ by AFM. J Struct Biol: 1998; 121 03 356 361
40. Andree H. A. Stuart M. C. Hermens W. T., et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem: 1992; 267 25 17907 17912
41. Rand J. H. Wu X. X. Andree H. A., et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med: 1997; 337 03 154 160
42. Vogt E. Ng A. K. Rote N. S. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol: 1997; 177 04 964 972
43. Cederholm A. Svenungsson E. Jensen-Urstad K., et al. Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol: 2005; 25 01 198 203
44. Rand J. H. Wu X. X. Quinn A. S., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol: 2003; 163 03 1193 1200
45. Gaspersic N. Ambrozic A. Bozic B. Majhenc J. Svetina S. Rozman B. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies. Rheumatology (Oxford): 2007; 46 01 81 86
46. Hanly J. G. Smith S. A. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol: 2000; 120 03 537 543
47. Rand J. H. Wu X. X. Andree H. A., et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a lupus procoagulant phenomenon. Blood: 1998; 92 05 1652 1660
48. de Laat B. Wu X. X. van Lummel M. Derksen R. H. de Groot P. G. Rand J. H. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood: 2007; 109 04 1490 1494
49. de Laat B. Derksen R. H. Urbanus R. T. de Groot P. G. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood: 2005; 105 04 1540 1545
50. de Laat B. Pengo V. Pabinger I., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost: 2009; 7 11 1767 1773
51. Brachvogel B. Dikschas J. Moch H., et al. Annexin A5 is not essential for skeletal development. Mol Cell Biol: 2003; 23 08 2907 2913
52. Akira S. Takeda K. Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol: 2001; 2 08 675 680
53. Kawai T. Akira S. Toll-like receptor downstream signaling. Arthritis Res Ther: 2005; 7 01 12 19
54. Beutler B. Du X. Poltorak A. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J Endotoxin Res: 2001; 7 04 277 280
55. Raschi E. Testoni C. Bosisio D., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood: 2003; 101 09 3495 3500
56. Cuadrado M. J. López-Pedrera C. Khamashta M. A., et al. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum: 1997; 40 05 834 841
57. Dobado-Berrios P. M. López-Pedrera C. Velasco F. Aguirre M. A. Torres A. Cuadrado M. J. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost: 1999; 82 06 1578 1582
58. Dobado-Berrios P. M. López-Pedrera C. Velasco F. Cuadrado M. J. The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum: 2001; 44 11 2467 2476
59. Sorice M. Longo A. Capozzi A., et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum: 2007; 56 08 2687 2697
60. Colasanti T. Alessandri C. Capozzi A., et al. Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood: 2012; 120 16 3360 3370
61. Raschi E. Borghi M. O. Grossi C. Broggini V. Pierangeli S. Meroni P. L. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus: 2008; 17 10 937 942
62. Pierangeli S. S. Vega-Ostertag M. E. Raschi E., et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis: 2007; 66 10 1327 1333
63. Akira S. Takeda K. Functions of toll-like receptors: lessons from KO mice. C R Biol: 2004; 327 06 581 589
64. Hoshino K. Takeuchi O. Kawai T., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol: 1999; 162 07 3749 3752
65. Manukyan D. Müller-Calleja N. Jäckel S., et al. Cofactor-independent human antiphospholipid antibodies induce venous thrombosis in mice. J Thromb Haemost: 2016; 14 05 1011 1020
66. Girardi G. Mackman N. Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule. Lupus: 2008; 17 10 931 936
67. Oliveira-Nascimento L. Massari P. Wetzler L. M. The role of TLR2 in infection and immunity. Front Immunol: 2012; 3 79
68. Satta N. Dunoyer-Geindre S. Reber G., et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood: 2007; 109 04 1507 1514
69. Satta N. Kruithof E. K. Fickentscher C., et al. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood: 2011; 117 20 5523 5531
70. Brandt K. J. Fickentscher C. Boehlen F. Kruithof E. K. de Moerloose P. NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost: 2014; 12 05 779 791
71. Müller-Calleja N. Köhler A. Siebald B., et al. Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome. Thromb Haemost: 2015; 113 05 1071 1083
72. Benhamou Y. Bellien J. Armengol G., et al. Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome. Arthritis Rheumatol: 2014; 66 11 3210 3220
73. May P. Woldt E. Matz R. L. Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med: 2007; 39 03 219 228
74. Mayer H. Duit S. Hauser C. Schneider W. J. Nimpf J. Reconstitution of the Reelin signaling pathway in fibroblasts demonstrates that Dab1 phosphorylation is independent of receptor localization in lipid rafts. Mol Cell Biol: 2006; 26 01 19 27
75. Riddell D. R. Vinogradov D. V. Stannard A. K. Chadwick N. Owen J. S. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res: 1999; 40 10 1925 1930
76. Yang X. V. Banerjee Y. Fernández J. A., et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci U S A: 2009; 106 01 274 279
77. Ulrich V. Gelber S. E. Vukelic M., et al. ApoE receptor 2 mediation of trophoblast dysfunction and pregnancy complications induced by antiphospholipid antibodies in mice. Arthritis Rheumatol: 2016; 68 03 730 739
78. Pennings M. T. Derksen R. H. Urbanus R. T. Tekelenburg W. L. Hemrika W. de Groot P. G. Platelets express three different splice variants of ApoER2 that are all involved in signaling. J Thromb Haemost: 2007; 5 07 1538 1544
79. Robertson J. O. Li W. Silverstein R. L. Topol E. J. Smith J. D. Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. Thromb Res: 2009; 123 04 644 652
80. Ulrich V. Konaniah E. S. Herz J., et al. Genetic variants of ApoE and ApoER2 differentially modulate endothelial function. Proc Natl Acad Sci U S A: 2014; 111 37 13493 13498
81. Wang L. Wang X. Laird N. Zuckerman B. Stubblefield P. Xu X. Polymorphism in maternal LRP8 gene is associated with fetal growth. Am J Hum Genet: 2006; 78 05 770 777
82. Lutters B. C. Derksen R. H. Tekelenburg W. L. Lenting P. J. Arnout J. de Groot P. G. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′ J Biol Chem: 2003; 278 36 33831 33838
83. Urbanus R. T. Pennings M. T. Derksen R. H. de Groot P. G. Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2′ J Thromb Haemost: 2008; 6 08 1405 1412
84. Ramesh S. Morrell C. N. Tarango C., et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest: 2011; 121 01 120 131
85. Romay-Penabad Z. Aguilar-Valenzuela R. Urbanus R. T., et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood: 2011; 117 04 1408 1414
86. Kolyada A. Porter A. Beglova N. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. Blood: 2014; 123 07 1090 1097
87. Kobayashi T. Stang E. Fang K. S. de Moerloose P. Parton R. G. Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature: 1998; 392 (6672): 193 197
88. Canaud G. Bienaimé F. Tabarin F., et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med: 2014; 371 04 303 312
89. Canaud G. Legendre C. Terzi F. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game. Lupus: 2015; 24 03 227 230
90. Girardi G. Berman J. Redecha P., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest: 2003; 112 11 1644 1654
91. Girardi G. Redecha P. Salmon J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med: 2004; 10 11 1222 1226
92. Redecha P. Franzke C. W. Ruf W. Mackman N. Girardi G. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest: 2008; 118 10 3453 3461
93. Pierangeli S. S. Girardi G. Vega-Ostertag M. Liu X. Espinola R. G. Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum: 2005; 52 07 2120 2124
94. Romay-Penabad Z. Liu X. X. Montiel-Manzano G. Papalardo De Martínez E. Pierangeli S. S. C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies. Ann N Y Acad Sci: 2007; 1108 554 566
95. Carrera-Marín A. Romay-Penabad Z. Papalardo E., et al. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus: 2012; 21 14 1497 1505
96. von Landenberg C. Lackner K. J. von Landenberg P. Lang B. Schmitz G. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. J Autoimmun: 1999; 13 02 215 223
97. Lackner K. J. von Landenberg C. Barlage S. Schmitz G. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Thromb Haemost: 2000; 83 04 583 588
98. Ikematsu W. Luan F. L. La Rosa L., et al. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum: 1998; 41 06 1026 1039
99. Proulle V. Furie R. A. Merrill-Skoloff G. Furie B. C. Furie B. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. Blood: 2014; 124 04 611 622
100. Nishimura M. Nii T. Trimova G., et al. The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. J Nephropathol: 2013; 2 02 114 121